CD59 and neuromyelitis optica: As an alternative approach, as motivated by the consequences of CD59 knockout [15, 17, 18], inhibition [15], and overexpression [21] in experimental animal models of NMO, here we investigate the therapeutic utility of pharmacological upregulation of complement regulator proteins in astrocytes.